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0 The Journal of Thoracic and Cardiovbjective: The congenitally bicuspid aortic valve is the most common etiologic
actor associated with clinically significant aortic stenosis and/or regurgitation in
ediatric patients. Beyond infancy, surgical intervention typically involves valve
epair with cusp thinning and commissurotomy or valve replacement, primarily with
ulmonary autograft in the current era. An aortic valve repair technique using
ricuspidization with cusp extension was introduced in 1999. This study compares
he midterm clinical outcome in patients undergoing valve repair by tricuspidization
ith cusp extension with those receiving a pulmonary autograft (Ross).
ethods: A retrospective study was performed on all consecutive patients with
ymptomatic bicuspid aortic valve disease who underwent tricuspidization with
usp extension or a Ross procedure between 1999 and 2005. In both groups, all
atients were at least 1 year of age at time of the operation.
esults: During this period, 21 children (median age 12.6 years, range 2.6–18 years)
nderwent tricuspidization with cusp extension (TCE group) and 25 children (me-
ian age 10.2 years, range 11.5 months–20.1 years) underwent the Ross procedure.
rior balloon valvuloplasty was performed in 5 (24%) of the children in the TCE
roup and 16 (64%) of the children in the Ross group. Prior surgical commissur-
tomy was performed in 4 (19%) TCE patients and in 9 (36%) Ross patients. During
median follow-up period of 36.4 months (range 2.5 months–7.4 years), 2 (10%)
atients in the TCE group required valve-preserving early revision of the repair, 2
10%) TCE patients required subsequent aortic valve replacement at 16 and 33
onths, 1 (4%) Ross patient required subsequent valve repair at 5 years, and 1 (4%)
oss patient underwent cardiac transplantation at 46 months. At 36 months, the
ctuarial freedom from reintervention on the aortic valve or autograft was 90% in
he TCE group, with 11 patients at risk, and 100% in Ross patients, with 13 patients
t risk (P  .39); the freedom from moderate valve dysfunction or reintervention
as 66% for TCE patients and 95% for Ross patients (P  .07). There were no
eaths, and all but 1 Ross patient remain in New York Heart Association class I.
onclusions: Reintervention rates in patients undergoing tricuspidization with cusp
xtension or a primary Ross procedure are similar. Valve performance in the TCE
roup is satisfactory at midterm follow-up, but the Ross repair appears to provide
reater stability of valve function. These results suggest that repair with valve
ricuspidization and cusp extension provides reliable palliation of the symptomatic
icuspid aortic valve.
resent in 1% to 2% of the population, the congenitally bicuspid aortic valve
is the most common etiologic factor associated with clinically significant
aortic valve stenosis in pediatric patients.1 Critical bicuspid aortic stenosis ypically treated by balloon valvuloplasty or surgical valvotomy in neonates and
ascular Surgery ● July 2007
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Dnfants. Beyond infancy, surgical interventions involve
alve repair techniques or valve replacement, primarily
sing the pulmonary autograft (Ross procedure) in the cur-
ent era. Although midterm results of the Ross procedure are
ncouraging,2-4 there is evidence of increased valve d-
unction related to abnormal growth of the autograft in
ounger patients.5,6 It has been reported that the pulmon
utograft is more prone to dysfunction in the setting of a
redominantly regurgitant native aortic valve7 or significant
ize mismatch between the native valve and autograft. Ad-
itionally, it has been proposed that the presence of a native
icuspid aortic valve is an additional risk factor for pulmo-
ary autograft dysfunction.8 Although early aortic valv
epair is an attractive option in these patients, techniques
hat preserve bicuspid geometry are associated with in-
reased risk of valve dysfunction and early valve replace-
ent.9 The technique of bicuspid aortic valve repair 
ricuspidization with cusp extension (TCE) was introduced
n our unit in 1999. This study compares the midterm
linical outcome in children undergoing valve repair with
CE and those receiving a pulmonary autograft.
atients and Methods
rom February 1999 to October 2005, 46 children (median age
3.3 years, range 11.5 months–20.1 years) underwent surgical
reatment of congenitally bicuspid aortic valve disease at our
nstitution. Indications for surgery were severe regurgitation or
ean gradient greater than 50 mm Hg or a combination of mean
radient greater than 50 mm Hg and moderate regurgitation.
Abbreviations and Acronyms
CL  confidence limits
TCE tricuspidization with cusp extension
ABLE 1. Comparison of data for patients undergoing valv
TCE (n  2
Age (y) 12.6 (2.6–18.0
Weight (kg) 49.5 (12.6–95
Aortic annulus (mm) 23 (14–34)
Aortic annulus (z-value) 2.1 (0.3–
Indication for surgery
Aortic insufficiency 11 (52%)
Aortic stenosis 1 (5%)
Insufficiency and stenosis 9 (43%)
 Moderate insufficiency 16 (76%)
 Moderate stenosis 10 (48%)
Prior interventions
Balloon valvuloplasty 5 (24%)
Surgical valvotomy 4 (19%)
Valve repair 0CE, Tricuspidization with cusp extension.
The Journal of Thoracwenty-one of these patients (mean age 12.6 years, range 2.6–18
ears) underwent aortic valve TCE and 25 patients (mean age 10.2
ears, range 11.5 months–20.1 years) underwent placement of a
ulmonary autograft (Table 1). The primary indication for sur
as aortic insufficiency in 11 (52%) TCE versus 5 (20%) Ross
P .023), aortic stenosis in 1 (5%) TCE versus 2 (8%) Ross (P
595), or combined aortic stenosis and insufficiency in 9 (43%)
CE versus 18 (72%) Ross patients (P  .044). The median
reoperative z-value for the aortic valve annulus (at the nadir of
he cusps) was 2.1 (range 0.3 to 9.2) in the TCE patients and
1.9 (range 4.4 to 8.7) in the Ross patients (P  .165).
oderate or greater preoperative aortic insufficiency was present
n 16 (76.2%) TCE versus 21 (84%) Ross patients (P  .71),
hereas moderate or greater aortic stenosis was present in 10
48%) TCE and 10 (40%) Ross patients (P  .766). Balloon
alvuloplasty had been previously performed on 5 (24%) TCE and
6 (64%) Ross patients (P  .007). Surgical commissurotomy had
een performed on 4 (19%) TCE patients and 9 (36%) Ross
atients (P  .173). Two (8%) Ross patients had previously
ndergone aortic valve repair. Precise anatomy and lesions are
escribed in Table 2.
ABLE 2. Comparison of the anatomy of patients undergo-
ng valve repair or pulmonary autograft
TCE (n  21) Ross (n  25)
hickened edges 15 (71%) 4 (16%)
usp dysplasia/thickening 5 (24%) 14 (56%)
rominent raphe 17 (80%) 21 (84%)
ommissural fusion 11 (52%) 11 (44%)
orn cusp 4 (19%) 8 (32%)
usp hypoplasia 4 (19%) 1 (4%)
usp calcification 1 (5%) 4 (16%)
ubaortic membrane 2 (10%) 3 (12%)
egetations 0 3 (12%)
CE, Tricuspidization with cusp extension.
pair or pulmonary autograft
Ross (n  25) P value
10.2 (1.0–20.1) .157
27.9 (9.4–84.0) .023
20 (9–38) .165
1.9 (4.4–8.7) .165
5 (20%) .023
2 (8%) .595
18 (72%) .044
21 (84%) .711
10 (40%) .766
16 (64%) .007
9 (36%) .173
2 (8%)e re
1)
)
.0)
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Dhoice of Procedure
ll patients were assessed by preoperative transthoracic echocardiog-
aphy to study the structure and function of both the aortic and
ulmonary valves. All patients were approved for TCE or Ross.
riteria for TCE included an aortic orifice that is equal to or greater
han normal (normalized for body surface area)10,11 after commissur-
tomy and division of the raphe, adequate mobility of all cusps at the
inge point, absence of cusp dysplasia involving the belly of the
usps, commissures that are free of calcification or exuberant fibrosis,
nd normal location of the coronary ostia. When these criteria were
et, TCE was the procedure of choice. When possible, we avoided
he pulmonary autograft in the presence of pure aortic regurgitation or
significant aorta–pulmonary size mismatch. Rationale for repair was
iscussed with the family and the patient. Ross and mecha
rosthesis was presented as an option during the preoperative appoint-
ent. It was stated during this appointment that the durability of the
epair is evaluated between 5 and 10 years.
urgical Technique
TCE. Through a full midline sternotomy, the anterior portion of
he pericardium was exposed and carefully trimmed. A generous
egment of pericardium was harvested before fixation in 0.625%
lutaraldehyde for 8 minutes and rinsing.12,13 When possible, peri-
ardium overlying the superior cavoatrial junction was preferentially
sed because it is characteristically thin and supple. 14 Cardiopulmo-
ary bypass was performed with bicaval and ascending aortic cannu-
ation. The aortic valve was exposed by a high transverse aortotomy
at least 1 cm above the anterior commissure) with extension deep
igure 1. A raphe joining two congenitally fused cusps is a com-
on element of the bicuspid aortic valve. Division of the raphe to the
ortic wall creates three functionally independent cusps before
ericardial leaflet extension. Source: Brizard C, d’Udekem Y, Al-
hoso N, Valvar disease in children. In: Yuh D, Vricella L, Baumgart-
er W, eds. The Johns Hopkins Manual of Cardiothoracic Surgery.
ew York, NY: The McGraw-Hill Companies; 2007. p. 1301–28. Re-
rinted with permission of the publisher.nto the noncoronary sinus (hockey-stick incision). Cold blood car- w
2 The Journal of Thoracic and Cardiovascular Surgery ● July 2ioplegic solution was given directly through the coronary ostia
mmediately after the aortotomy and then at 20-minute intervals. The
usps were then carefully examined and the annulus was measured
ith Hegar dilators. The raphe joining the congenitally fused cusps
as divided to the aortic wall (Figure 1). When commissural 
as present, commissurotomy was performed before determining the
ize of the annulus. Nodular irregularities along the surfaces of appo-
ition of the cusps were removed.
Measurements of the length of the free edges of the three cusps
ere obtained and rectangular pieces of glutaraldehyde-treated
ericardium were created. The height at the midportion of each
ericardial extension was adjusted to the anatomy of each cusp and
he underlying mechanism of valve dysfunction. Higher patches
ere used in the setting of very abnormal cusp tissue and signif-
cant cusp height discrepancy. In general, pericardial extensions
ere at least 5 mm and occasionally up to 7 mm in height. The
eight of coapting patches was increased toward the division of the
aphe to compensate for the lack of a true interleaflet triangle and
o elevate the hinge point of the cusps (Figure 2). The
xtensions were sewn to the free edge of each cusp with running
-0 polypropylene suture. Tissue gathering was used to correct the
longated free edges of the native cusps. A Frater15 stitch was used
o join the three patches at the center of the valve to allow precise
djustment of any excessive length of patch. New commissures
igure 2. The height of coapting pericardial patches is increased
oward the neocommissure to compensate for the lack of a true
nterleaflet triangle and to elevate the hinge point of the leaflets.
ach new commissure is constructed by suturing the apposing short
dges of each patch together and to the aortic wall, creating an
longated vertical axis of the native commissures. Source: Brizard C,
’Udekem Y, Alphoso N. Valvar disease in children. In: Yuh D,
ricella L, Baumgartner W, eds. The Johns Hopkins Manual of
ardiothoracic Surgery. New York, NY: The McGraw-Hill Compa-
ies; 2007. p. 1301–28. Reprinted with permission of the publisher.ere constructed with a running suture apposing the short edges of
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Dwo opposing patches together and to the aortic wall, creating an
longated vertical axis of the native commissures (Figure 2).
op part of this suture was reinforced with a single simple trans-
xing stitch. Intraoperative transesophageal echocardiography was
sed to assess aortic valve function after TCE repair. All patients
ndergoing TCE received intravenous heparin (10 units · kg1 ·
1 for 72 hours) and daily aspirin for at least 6 months after the
peration.
Ross. After determining that the aortic valve was not amenable
o TCE repair, we harvested the pulmonary autograft. Then almost
ll infundibular muscle from the autograft was removed. The
scending aorta was divided and the coronary ostia were mobi-
ized. Aortic valve cusps and associated dysplastic tissue were
emoved. When a small aortic annulus was present, an annulus-
nlarging procedure was performed. Three (12%) patients under-
ent a Konno septoplasty with a Dacron septal patch and 5 (20%)
nderwent a modified Konno septoplasty, involving direct anasto-
osis of the pulmonary autograft to the incised septum. The
utograft was implanted as a mini-root, using running polypro-
ylene suture reinforced with a strip of glutaraldehyde-treated
ericardium or Teflon felt along the septum. The suture line was
ow in the left ventricular outflow tract, following a horizontal
lane immediately below the nadir of the excised native aortic
alve cusps. The coronary buttons were implanted into facing
inuses. Continuity between the autograft and ascending aorta was
stablished at the level of the sinotubular junction with polypro-
ylene suture. One patient underwent freehand implantation of the
ulmonary autograft. The pulmonary outflow tract was recon-
tructed with either aortic or pulmonary homograft. Intraoperative
ransesophageal echocardiography was used to assess neoaortic
alve and pulmonary homograft function.
ollow-up
ll patients underwent transthoracic echocardiographic examina-
ion before hospital discharge and then usually at 6-month inter-
als unless a change in clinical examination or status was noted.
ean patient follow-up for the series was 36.4 months (range 2.5
onths–7.4 years). Follow-up data were complete for all patients.
tatistical Methods
tatistical analysis was performed with Stata Version 8 software
StataCorp LP, College Station, Tex). Mean and sample propor-
ions are expressed with 95% confidence limits (CL), using con-
inuity correction for the upper and lower limits. Groups were
ompared by unpaired t tests for continuous variables or Fisher
xact tests for dichotomous variables. Survival analysis was per-
ormed by the Kaplan–Meier method and comparison of survival
urves was performed by the log–rank test. Univariate analysis
ith logistic regression was used to test risk factors for failure.
his study was done within the guidelines established by our
nstitutional human research ethics committee.
esults
CE
CE was performed in all patients who fulfilled the selec-
ion criteria described in the “Patients and Methods” sec-
ion. Two patients required early revision of the repair— i
The Journal of Thoracuring the same operation for one and on the second
ostoperative day for the other. The native valve was pre-
erved in both patients; one required pericardial extension
eplacement with higher patches, and the other needed a
mall triangular resection at the center of one of the patches.
ostoperative echocardiography demonstrated a peak out-
ow tract gradient greater than 20 mm Hg in 3 patients (22,
2, and 27 mm Hg). Residual aortic regurgitation at hospital
ischarge and at latest follow-up is presented in Figu
uring a median follow-up of 34.7 months (range 8 months-
.5 years), 1 patient underwent a Ross procedure for endo-
arditis 16 months after TCE and 1 patient required bio-
rosthetic aortic valve replacement for progressive aortic
nsufficiency 33 months after repair (9.5%, CL: 0.1-32). In
patients a moderate aortic regurgitation was first diag-
osed 9, 10, 31, and 40 months, respectively, after the TCE;
evere regurgitation did not develop in any patient (Fi
). At latest follow-up, the median peak instantane
oppler gradient was 20 mm Hg (range 10-55 mm Hg) with
peak gradients greater than 20 mm Hg (23 mm Hg, n 
; 30 mm Hg first noted at 38 months, 36 mm Hg first noted
t 26 months, and 55 mm Hg first noted at 30 months). All
atients are in New York Heart Association class I.
oss
f the 25 Ross patients, 9 had postoperative morbidity, includ-
igure 3. The degree of residual aortic regurgitation at the time of
ospital discharge (upper panels) and at latest follow-up (lower
anels) in patients undergoing tricuspidization with leaflet ex-
ension (TCE, left panels) and pulmonary autograft (Ross, right
anels). TCE, Tricuspidization with cusp extension.ng mediastinitis (n 1), complete atrioventricular block (n
ic and Cardiovascular Surgery ● Volume 134, Number 1 93
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D), severe left ventricular dysfunction (n 1), right ventricular
utflow tract stenosis requiring early reoperation (n  1),
elayed sternal closure (1), bilateral sensoneuronal deafness (n
1), and inferior myocardial infarction (n 1). Postoperative
chocardiography demonstrated a peak outflow tract gradient
reater than 20 mm Hg in 1 patient. The degree of neoaortic
egurgitation at hospital discharge and at latest follow-up is
resented in Figure 3. During a median follow-up of 
onths (range 2.5 months-7.4 years), 1 patient required repair
f the pulmonary autograft for severe regurgitation at 59
onths, 1 patient was listed for transplantation at 33 months
or severely restrictive left ventricular dysfunction and success-
ully underwent transplantation at 46 months, and 1 patient had
arly moderate regurgitation at 8 months (4%, CL: 0-22.3).
uring the follow-up period, 2 patients had a mild gradient
evelop across the left ventricular outflow tract. At latest
ollow-up, the patient who underwent transplantation is in New
ork Heart Association class II and all others are in class I.
During this time, 2 (8%, CL: 1.3-27) Ross patients
equired surgical or catheter-based intervention for right
entricle–pulmonary artery conduit failure.
tatistical Analysis
wo (10%) TCE and 6 (25%) Ross patients were free of
ortic insufficiency (P  .26) at latest follow-up. The de-
ree of aortic regurgitation at discharge was similar between
he two groups (P  .06) but significantly different at latest
ollow-up (P .027). The degree of regurgitation increased
ignificantly for the TCE patients (P .035), whereas it did
igure 4. Kaplan–Meier curve comparing freedom from surgical
eintervention on the aortic valve in patients undergoing pulmo-
ary autograft (Ross, solid lines) and those undergoing tricus-
idization with leaflet extension (TCE, dashed lines). Freedom
rom surgical reintervention at 36 months was 100% for Ross
atients (13 patients at risk) and 90% for TCE patients (11 patients
t risk) (P  .39). TCE, Tricuspidization with cusp extension.ot for the Ross patients (P  .24). The actuarial freedom s
4 The Journal of Thoracic and Cardiovascular Surgery ● July 2rom aortic valve reoperation was comparable between the
wo groups (log–rank test, P .39) (Figure 4). The actuari
reedom from moderate or greater aortic regurgitation or
eoperation (excluding right ventricular outflow tract proce-
ures and cardiac transplantation) was also comparable be-
ween the two groups (log–rank test, P  .075) (Figure 5)
According to logistic regression, univariate analysis of
ge, sex, prior surgical intervention, prior surgical valvot-
my, prior aortic balloon dilation, replacement of one whole
usp at surgery, grade of preoperative aortic regurgitation
nd preoperative mean instantaneous gradient failed to dem-
nstrate predictive factors for TCE failure. However, there
as a trend toward an association between younger age at
he time of TCE and subsequent development of aortic
egurgitation (P .06 for patients younger than 100 months
f age and P  .02 for patients younger than 10 years). No
nivariate analysis was performed for the Ross patients
wing to the paucity of events.
Multivariate logistic regression was also performed with
alve dysfunction or occurrence of reoperation as the de-
endent variable whereas the independent variables in-
luded the type of operation (TCE or Ross), age, body
urface area, prior surgical intervention, mean valve gradi-
nt before, the dominant preoperative valve disease, and the
rade of the preoperative valve regurgitation. There were no
ignificant predictive variables.
Cox proportional analysis was performed, with time to
eoperation used as the dependent variable. There were no
igure 5. Kaplan–Meier curve comparing freedom from reopera-
ion or the development of moderate or greater aortic regurgita-
ion in patients undergoing pulmonary autograft (Ross, solid lines)
nd those undergoing tricuspidization with leaflet extension (TCE,
ashed lines). Freedom from reoperation or moderate or greater
ortic regurgitation at 36 months was 90% for Ross patients (13
atients at risk) and 75% for TCE patients (10 patients at risk) (P
.075). TCE, Tricuspidization with cusp extension.ignificant predictive variables.
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Discussion
ntroduced by Ross16 in 1967, the pulmonary autograft h
ecome an important therapeutic option for patients with se-
ere aortic valve disease. In the young adult population, the
ulmonary autograft has proven to be a practical alternative to
rosthetic aortic valve replacement, with reported freedom
rom reoperation of 75% at 10 years17 on the autograft. How-
ver, additional procedures are necessary to address subse-
uent right ventricle–pulmonary conduit dysfunction. A major
rawback of the Ross procedure is that the patient is converted
rom single-valve disease to iatrogenic 2-valve disease.
Surgical repair of the congenitally bicuspid aortic valve
s an attractive alternative to valve replacement. Valve re-
air preserves the native aortic root and, therefore, enables
ormal annular growth to occur. This is an important con-
ideration in the younger child whose aortic annulus will not
ccommodate an adult-sized prosthesis. The goal of aortic
alve repair in these patients is to prevent secondary
hanges in left ventricular geometry and function and to
acilitate sufficient annular growth to accommodate an aor-
ic valve prosthesis when necessary. Furthermore, aortic
alve repair preserves the pulmonary valve and does not
reclude a subsequent pulmonary autograft.18 Conversely,
he results of bicuspid aortic valve repair in children are
requently not encouraging, with some groups reporting that
pproximately 50% of patients will require valve replacement
r exhibit significant valve dysfunction within 2 years.9
Several surgical techniques involving valve reconstruc-
ion with autologous tissue have been developed since Sen-
ing’s initial report19 on the use of fascia lata to reconst
he aortic valve in 1967. Although some authors discourage
he use of cusp extension for aortic insufficiency in chil-
ren,20 experience with autologous pericardial cusp exte-
ion techniques for rheumatic aortic valve repair has dem-
nstrated reasonable midterm durability in both adults and
hildren.21-23 Early24 and midterm21 results of cusp exten-
ion techniques to address bicuspid valve dysfunction are
lso encouraging. Using univariate analysis, van Son and
olleagues9 identified the presence of a bicuspid aortic v
s an independent risk factor for early repair failure. When
ompared with cusp extension for bicuspid aortic valve
isease, valve repair involving tricuspidization with cusp
xtension (TCE) appears to offer improved durability, albeit
ot statistically significantly so.21
Surgical repair of the bicuspid aortic valve must frequently
ddress both residual stenosis and insufficiency, which may or
ay not be related to prior balloon dilation. We believe that it
s critical not only to increase the cusp zone of apposition but
lso to establish tricuspid geometry to provide an optimal
ffective orifice area. Balloon valvuloplasty during childhood
ends to disrupt valves along planes of least resistance, causing
amage to delicate cusp tissue, which leads to valvular insuf-
ciency.25 Balloon valvuloplasty had been performed in only w
The Journal of Thorac4% of patients eligible for TCE in this series, whereas 64% of
atients who were not TCE candidates had undergone previous
alloon valvuloplasty. It may be beneficial to consider surgical
alvotomy, rather than balloon valvuloplasty, in infants with
ritical bicuspid aortic stenosis and an adequate aortic annulus.
Before the introduction of the Ross procedure, the sur-
ical strategy for congenital aortic valve disease at The
oyal Children’s Hospital was to delay valve replacement
y performing palliative valve repairs until an adult-sized
echanical prosthesis could be used.26 The cusp extension
echnique for bicuspid aortic insufficiency was introduced
n our unit at the same time as the Ross procedure. From
996 to 1999, we performed cusp extensions, preserving
icuspid anatomy. The results in these early patients were
isappointing, with excessive residual gradients and early
ailure owing to recurrent regurgitation (Appendix Figure
he technique of TCE was introduced in 1999. It is derived
rom valve tricuspidization, as promoted by Tolan and as-
ociates,27 and cusp extension, first described by Senning19
The morbidity in our series of the Ross procedure is im-
ortant, and this should be an argument in favor of continuing
xploration of the valve repair techniques, but the autograft
alve function at the term of follow-up is excellent. Only 2
atients had autograft failure, 1 of whom required reoperation.
he stable performance of the autograft in this study compares
ery favorably with other series reported in the recent litera-
ure,5,28 where the rate of reoperation on the autograf
uperior to the rate of reoperation on the right ventricular
utflow tract. In our series, this may reflect the patient selection
nd the use of aortic valve repair in patients who are poor
andidates for the Ross procedure. The predominant preoper-
tive disease was pure aortic regurgitation in the TCE group (P
.023), whereas the Ross group predominantly had combined
egurgitation and stenosis (P  .044), with a tendency toward
maller annuli (range 4.4 to 8.7 versus 0.3 to 9).
lthough there was no statistically significant increase in au-
ograft regurgitation over the time of follow-up, we did observe
slight increase in the mean regurgitation score in the Ross
atients.
Over the time of the follow-up, the two groups had
omparable reoperation rates; however, it is clear that aortic
alve function in TCE patients is less stable than in Ross
atients. Identification of risk factors contributing to TCE
ailure would clearly be beneficial for future patient selec-
ion, but we failed to detect any significant factors. The fact
hat we were unable to identify risk factors for TCE or Ross
ailure may suggest that our choice of procedure at the time
f surgery was appropriate or that the power of the study is
imited owing to the small number of events and/or patients.
atients at risk for failure with one procedure were directed
oward the alternate procedure. Although not statistically
ignificant, younger age at time of operation was associated
ith subsequent development of aortic insufficiency in TCE
ic and Cardiovascular Surgery ● Volume 134, Number 1 95
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Datients. This is disappointing inasmuch as limiting TCE to
lder patients defeats the primary benefit of valve repair in chil-
ren, which is to delay valve replacement as long as possible.
Although early valve function after TCE is excellent, the
esults from this series and others21,29 suggest that long-term
ollow-up will be associated with an increased rate of reopera-
ion. The importance of the characteristics of the material used
or cusp extension in the long-term result is obvious and,
herefore, the selection of material is essential. We belong to a
chool that has extensively studied and promoted the use of
lutaraldehyde-treated autologous pericardium.12,13,22,30,31 We
arvest the thinnest portion of the pericardium and carefully
lear it of any scar tissue. We have reduced the duration of the
reatment to 8 minutes. However, other materials have been
sed and advocated by other teams. Most centers now avoid using
lutaraldehyde-treated bovine32 or equine pericardium. Ther
s one case report describing the use of dye-mediated photo-
xidation bovine33 pericardium in this context without cu
xtension but without follow-up. Kalangos and associate34
lso report good midterm results with the use of untreated
utologous pericardium for rheumatic aortic valve repair. Sim-
lar reports by Grinda and colleagues23 and others22 with large
eries yield good midterm results as well for the cusp extension
ith glutaraldehyde-treated pericardium. Although thin ex-
anded polytetrafluoroethylene appears to provide satisfactory
unction during early follow-up in the pulmonary position, this
aterial is likely to tear at systemic pressure and its use in the
ystemic circulation has not been reported. In this context, and
lthough the results are imperfect, there is no strong argument
o justify for us a switch to an alternative material. Most teams
nvolved with this operation would agree that the ideal material
or aortic valve repair is still to be found.
The TCE is particularly well suited for the thickened
usps seen in pediatric patients with a history of valve
tenosis or when significant secondary dysplasia contributes
o increased valve gradient. However, it must be noted that
ther repair techniques exist for bicuspid aortic valve dis-
ase. In the setting of a bicuspid valve with thin cusps,
ymmetrical commissures without raphe and elongation of
ne free edge, triangular resection of the free edge without
usp extension is a very efficient repair technique.35,36
hese patients often first present in the second or third
ecade and are rare in pediatrics settings.
imitations
e recognize that this is a nonrandomized retrospective series.
he patients are essentially different, because the two tech-
iques address and are best suited for dissimilar valve anat-
my. Therefore, the statistical comparison between the two
roups should be interpreted carefully and more as an indica-
ion of the midterm performance of the TCE benchmarking
ith the Ross procedure.
6 The Journal of Thoracic and Cardiovascular Surgery ● July 2onclusions
his series demonstrates that TCE is a reliable palliation for
ymptomatic bicuspid aortic valve disease beyond infancy and is
ssociated with very little morbidity. TCE should not be viewed as
n alternative to the pulmonary autograft, which has very good
idterm results. When integrated into a comprehensive surgical
trategy, TCE may delay the timing of the Ross procedure or other
ortic valve replacement while preserving ventricular function,
specially in patients less suited for pulmonary autograft.
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ppendix Figure 1. Actuarial freedom from reoperation for aortic
alve repair for bicuspid aortic valve (Royal Children’s Hospital,
996-1998) with preservation of the bicuspid physiology. N  5. The
nly patient of the 5 with a long-term satisfactory result has not hadlcusp extension with pericardium. The other 4 had cusp extension.
The Journal of Thorac6. Casselman FP, Gillinov AM, Akhrass R, Kasirajan V, Blackstone EH,
Cosgrove DM. Intermediate-term durability of bicuspid aortic valve
repair for prolapsing leaflet. Eur J Cardiothorac Surg. 1999;15:302-8.
iscussion
r Glen Van Arsdell (Toronto, Ontario, Canada). Dr Caldarone,
y partner, was the invited commentator. He was unable to be
ere. I am providing what are essentially his comments.
This is an impressive report describing TCE for bicuspid aortic
alves compared with the Ross procedure. The results have been
nalyzed with an appropriate degree of caution, recognizing the
ariable nature of outcomes with leaflet extension.
The hallmark of a good operation is one that is easily repro-
uced and produces consistent results. In this respect, I think that
t the Hospital for Sick Children we are still in a development
hase with the leaflet extension technique. We have some diffi-
ulty verbalizing why some valves simply do not appear to be
epairable. We know them when we see them, but cannot always
ay why. And when we do repair a valve, we have difficulty
etermining what technical details lead some to develop progres-
ive insufficiency while others do not.
The solution for this dilemma is the development of a finer
ocabulary describing the anatomy of the valve disease and better
escription of the components of the procedure performed. With a
etter vocabulary we can develop more consistency in our tech-
iques and move the leaflet extension technique from an artistic
peration to a more consistent, reproducible, and durable proce-
ure.
Along the lines of better description of the problems, my
uestions are as follows:
The bicuspid aortic valve represents a spectrum of development
rom a well-developed but fused commissure to a nearly absent
udimentary raphe. One would anticipate better results with tricus-
idization in the presence of a well-developed but fused commis-
ure. Are you able to comment on the degree of development of the
used commissure and the impact that this had on your intraoper-
tive decision-making, as well as the durability of the subsequent
epair?
Dr McMullan. All the patients in this study had a bicuspid valve
ith a well-developed raphe. We believe that a well-developed raphe
s necessary for this type of repair because it implies the presence of
hree coronary sinuses; we think that this type of valve should benefit
rom returning to a three-cusp type of physiology.
Dr Van Arsdell. So is it fair to infer that if it is really a true
icuspid valve with almost no hint of autotricuspidization, you
ecommend a Ross operation?
Dr McMullan. Yes, we would perform a Ross operation or
erhaps a different type of repair.
Dr Van Arsdell. A large proportion of your patients had
ndergone balloon aortic valvuloplasty before their surgical pro-
edure. Typically this results in tearing of the leaflet rather than the
ommissure. The tear tends to extend to the base of the cusp. Does
he morphology of the tear dictate the choice between a Ross and
leaflet extension technique? Furthermore, do all torn leaflets
equire leaflet extension or can they be repaired by other published
echniques?
Dr McMullan. The selection criteria for repair, as outlined in
he talk, indicate that any involvement of the hinge point, the
owest portion of the valve leaflet, would preclude repair. The idea
ic and Cardiovascular Surgery ● Volume 134, Number 1 97
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Ds to avoid a suture line that limits valve mobility. A larger
ercentage of patients in the Ross group had balloon dilation.
herefore, according to our selection criteria, they underwent a
oss procedure.
Dr Van Arsdell. If I am understanding your answer correctly,
ou really would not construct something where the predominant
roportion of the leaflet is derived from pericardial tissue; is that
orrect?
Dr McMullan. That is correct. Two patients required extensive
eaflet replacement early in the study. Those patients experienced
arly failure.
Dr Van Arsdell. Finally, I think that the problems we face are
hat some of the valves we want to repair are mixed lesions and
requently these involve patients who had previous aortic stenosis
ssues. The question is, a priori, before the operation, are you able
o decide, based on echocardiographic criteria and your preoper-
tive evaluation, with some degree of probability (ie, gradients or
haracteristics of mobility in the leaflet), which patients on a
robability basis are going to need a Ross operation versus those
hat would need a repair?
Dr McMullan. This is an important question. We feel believe
he outcome of both procedures should improve with the appro-
riate selection of patients. According to our selection criteria, a
atient with pure aortic insufficiency or a large annulus would be
ore suitable for repair, whereas patients with a negative z-value
or the annulus should receive a Ross–Konno procedure. Because
ur decision to perform one procedure over another was based on
everal factors, it is difficult to say whether any single factor would
ignificantly affect the outcome of these procedures. This was not
randomized study; it is likely that we directed patients who were
t higher risk for a Ross toward valve repair, and vice versa.
onsequently, multivariate analysis of potential risk factors did not
dentify any factors that contributed to early failure. This supports
he appropriateness of our selection criteria.
Dr Van Arsdell. I would say, based on reading your manu-
cript and listening to your presentation, that you have less residual
tenosis than we do. This implies that we are making a different
ntraoperative decision to repair valves that are going to have a net
ess orifice. Perhaps we are being more aggressive about the raphe
han you are. I’m not sure that this is the right decision. We need
o begin to grapple with that and figure out which patients are best
erved.
Dr Bahaaldin Alsoufi (Toronto, Ontario, Canada). Obviously
hen you repair the valve, you try to make it function as close to
ormal as possible. In reality, you do not leave the operating room
ith a normal valve and often you have some residual defects,
ither stenosis or regurgitation. To further correct residual regur-
itation, you may cause worsening stenosis. Those residual lesions
ill progress with time and may contribute to late repair failure.
ow do you manage those patients with residual lesions? How
uch gradient do you accept, or how much regurgitation on r
8 The Journal of Thoracic and Cardiovascular Surgery ● July 2ostrepair transesophageal echocardiogram will you accept before
ou decide to reinstitute cardiopulmonary bypass for either revi-
ion of the repair or replacement of the aortic valve?
Dr McMullan. As Dr Van Arsdell alluded, this is a custom
rocedure. It has not been standardized and much of the decision-
aking is based on the surgeon’s personal experience and his
omfort level with the amount of residual insufficiency after repair.
In general, if we found more than mild insufficiency after
epair, we would either revise the repair or proceed to a Ross. In
act, the 2 patients who required early revision were found to have
oderate insufficiency afte the initial repair. We elected to revise
he repair at that time. In general, we do not attempt valve repair
nless we are very confident that we will achieve a satisfactory
esult so that we avoid a situation in which we must replace a valve
fter unsuccessful repair.
Dr John W. Brown (Indianapolis, Ind). I have two questions.
irst, did age of the patient factor into which route you took? You
ried to do a repair on the smaller children to try to let the annulus
row so you could come back and do a Ross; did that play a role?
did not get that from your presentation.
Dr McMullan. Age did not factor into our decision-making.
ultivariate analysis of several factors, including age, failed to
dentify specific risk factors for failure. However, our decision to
erform either procedure was biased by our stated selection crite-
ia. Perhaps something like age would be identified as a risk factor
or one procedure or the other in a randomized study.
Dr Brown. Second, although the Ross registry is not a perfect
udge of how durable the Ross operation is, there are over 6000
atients in it, and the freedom from autograft excision is still 85%
t 25 years. How do you think the repair technique is going to hold
p? Your follow-up is at about 4 or 5 years at this point, and with
late failures, and, as you stated, it would seem that this is a
alliative operation and probably is not going to compete with the
oss once you get out past 5, 6, or 7 years. Your comments.
Dr McMullan. I agree completely. The Ross is a very good
rocedure and, in appropriately selected patients, long-term results
re very good. We are suggesting that this repair technique may be
seful as an adjunct to the Ross procedure. By performing valve
epair in patients who may be poorer candidates for the Ross
rocedure, we may avoid negative aspects of the Ross, including
ntrinsic weakness of the autograft, disruption of the right ventricular
utflow tract, and converting 1-valve disease to 2-valve disease.
Certainly a large percentage of patients undergoing valve repair
ill ultimately move on to valve replacement. It is our hope that by
nitially performing valve repair, the patient can safely wait for a
ore permanent valve replacement later in life.
Dr Brown. What percentage of these patients do you think will
ave a good functioning aortic valve 10 to 15 years after the
epair? Are you predicting 50% or 25%?
Dr McMullan. I think we have shown that this technique of
epair is a good palliative procedure but remains a palliation.
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